Melbourne Clinical Trials

The Mind Function Study

The study drug is exploring a potential new treatment for Tuberous Sclerosis Complex (TSC), and Focal Cortical Dysplasia (FCD).

30 nights
1 visits

This study is an evaluation of a new potential treatment for certain brain disorders, including GRIN-related disorders, Tuberous Sclerosis Complex (TSC), and Focal Cortical Dysplasia (FCD).

This first phase is important before testing the treatment in people with these brain disorders. By joining, you will help research that could improve future treatments and make a positive impact on people and families dealing with these conditions.

Call us on 1300 109 508 to discuss your eligibility today!

Eligibility

Biological Sex Female and Male
Age 18-55 years old
BMI ≥18.0 - ≤32.0kg/m²
Weight ≥50kg
Medication Not taking any medication
Medical History No significant medical history
Smoking History Non-smokers